Nicardipine or Nitroglycerin in Patients with Failed Percutaneous Coronary Angioplasty: Effect on Myocardial Diastolic Function

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 5, 2003, Pages 604-612

  Casthely, Pierre A ^a   Bunik, Tania ^a   Casthely, Pierre Alex ^a   Yoganathan, Thil ^a   Komer, Claudia ^b   Mekhjian Jr , Harouthune ^a  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

Diastolic dysfunction; Doppler tissue imaging; Mitral annulus velocity; Nicardipine; Nitroglycerin; PTCA

Indexed keywords

ANESTHETIC AGENT; FENTANYL; GLYCERYL TRINITRATE; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NICARDIPINE; VECURONIUM;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIASTOLE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; INTRACORONARY INFUSION; M MODE ECHOCARDIOGRAPHY; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0142094660     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00204-0     Document Type: Article

References (37)

1. Koolen JJ, Visser CA, David GK, et al: Transcsophageal echocardiographic assessment of systolic and diastolic dysfunction during PTCA. J Am Soc Echocardiogr 3:374-383, 1990
2. Wijns W, Serruys PW, Slager CJ, et al: Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure relaxation. J Am Coll Cardiol 7:455-463, 1986
3. Kass DA: Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relaxation in humans. Circulation 81:447-460, 1990
4. Labovitz AJ, Lewen MK, Kern M, et al: Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol 19:748-755, 1987
5. Rossvoll O, Harle LK: Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: Relations to left ventricular diastolic pressures. J Am Coll Cardiol 21:1687-1696, 1993
6. Viser CA, Koolen JJ, van Wezel HB, et al: Transesophageal echocardiography: Technique and clinical applications. J Cardiothorac Anesth 2:74-91, 1988
7. Ofili EO, Nanda NC: Color Doppler imaging of the myocardium: Current status and potential clinical applications. Ultrasound Med Biol 24:177-185, 1998
8. Bach DS, Armstrong WF, Donovan CL, et al: Quantitative Doppler tissue imaging for assessment of regional myocardial velocities during transient ischemia and reperfusion. Am Heart J 132:721-725, 1996
9. Rambaldi R, Poldermans D, Vletter WB, et al: Tissue Doppler imaging and the quantification of myocardial function. Int J Card Imaging 16:241-250, 1998
10. Garot J, Diebold B, Derumeaux GA, et al: Comparison of regional myocardial velocities assessed by quantitative 2-dimensional and M color Doppler tissue imaging: Influence of the signal-to-noise ratio of color Doppler myocardial images on velocity estimators of the Doppler tissue imaging system. J Am Soc Echocardiogr 12:1093-110, 1998
11. Casthely PC, Shah C, Mekhjian H, et al: Left ventricular diastolic function after coronary artery bypass grafting: A correlative study with three different myocardial protection techniques. J Thorac Cardiovasc Surg 114:254-260, 1997
12. Koolen JJ, van Wezel HB, Visser CA, et al: Nicardipine for preservation of myocardial metabolism and function in patients undergoing coronary artery surgery. Anesthesiology 71:508-518, 1989
13. Lambert CR, Pepine CJ: Effects of intravenous and intracoronary nicardipine. Am J Cardiol 64:8H-15H, 1989
14. de Jong JW: Cardioplegia and calcium antagonists: A review. Ann Thorac Surgery 42:593-598, 1986
15. Myers ML, Bolli R, Likich RF, et al: Enhancement of recovery of myocardial function after reversible regional ischemia. Circulation 72:921-927, 1985
16. Weisel RD, Goldman BS, Lipson IH, et al: Optimal myocardial protection. Surgery 84:812-820, 1978
17. Gualati VK, Katz WE, Follansbee WP, et al: Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol 77:979-984, 1996
18. Dougherty AH, Naccarelli GV, Gray EL, et al: Congestive heart failure with normal systolic function. Am J Cardiol 54:778-782, 1984
19. Kessler KM: Heart failure with normal systolic function-Update of prevalence, differential diagnosis, prognosis and therapy. Arch Intern Med 148:2109-2111, 1988
20. Kloner RA, Ellis SG, Lange R, et al: Studies of experimental coronary reperfusion: Effect on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 68:8-15, 1983 (suppl)
21. Piscione F, Hugenholtz PG, Serruys PW: Impaired left ventricular filling dynamics during percutaneous transluminal angioplasty for coronary artery disease. Am J Cardiol 59:29-37, 1987
22. Whiting RL: Animal pharmacology of nicardipine and its clinical relevance. Am J Cardiol 59:3J-8J, 1987
23. Alps BJ, Calder C, Wilson A, et al: The beneficial effect of nicardipine on the healing of myocardial infarcts in dogs. Arzneim Forsch 33:1638-1646, 1983
24. Hanet C, Rousseau MF, Vincent MF, et al: Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol 59:1035-1040, 1987
25. Mori F, Miyamoto M, Tsuboi H, et al: Clinical trial of nicardipine cardioplegia in pediatric cardiac surgery. Ann Thorac Surg 49: 413-418, 1990
26. Kloner RA, Ganote CE, Jennings RB: The "no-flow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496-1508, 1974
27. Miyauchi T, Yanagisawa M, Tomizawa T, et al: Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2:53-54, 1989
28. Vanhaecke J, Flameng W, Borgers M, et al: Evidence for decrease of coronary flow reserve in viable postischemic myocardium. Circ Res 67:1201-1210, 1990
29. Yanagisawa M, Masaki T: Endothelin, a novel endothelium-derived peptide: Pharmacologic activities, regulation and possible roles in cardiovascular control. Biochem Pharm 38:1877-1883, 1989
30. Matsuyama K, Yasue H, Okumura K, et al: Increased plasma levels of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 68:991-995, 1991
31. Hanaki Y, Sugiyama S, Ajioka M, et al: Acceleration of recovery of mitochondrial function after coronary reperfusion by various coronary dilating drugs in canine hearts. J Cardiovasc Pharmacol 13:336-341, 1989
32. Itoh Y, Yanagiawa M, Ohkubo S, et al: Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: Identity of human and procaine endothelin. FEBS Lett 231:44-444, 1988
33. Hirata Y, Yoshimi H, Takata S: Cellular mechanism by action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 154:868-873, 1988
34. Clozel JP, Clozel M: Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 65:1193-1198, 1989
35. Eaton LW, Weiss JL, Bulkley BH, et al: Regional cardiac dilatation after acute myocardial infarction. Recognition by two-dimensional echocardiography. N Engl J Med 300:57-66, 1979
36. Visser CA, Kan G, Lie KI, et al: Apex two-dimensional echocardiography: Alternative approach to quantification of acute myocardial infarction. Br Heart J 47:461-466, 1982
37. Gibson RS, Bishop HL, Stamm RB, et al: Value of early two-dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol 49:1116-1124, 1982